European Healthtech startup funding raised during 2020.
In 2020, 490 European Healthtech companies raised a combined €6.2B across 518 funding rounds. UK led by capital raised, and Bpifrance was the most active investor. Data as of 21 Aug 2026.
| Company | Stage | Date | Amount |
|---|---|---|---|
| CureVac | Early VC | Jun 2020 | €300M |
| Kry | Series C | Jul 2020 | €140M |
| Oxford Nanopore Technologies | Other | Apr 2020 | €124M |
| Freeline Therapeutics | Series C |
43 exits · €2.5B disclosed.
| MYR GmbH | Acquisition | Oct 2020 | €1.1B |
| Polyplus-Transfection | Acquisition | Feb 2020 | €460M |
| Galecto | Acquisition | Jan 2020 | €398M |
| MaSTherCell | Acquisition | Feb 2020 | €285M |
| Nanox Imaging | IPO | Aug 2020 | €140M |
| Fiagon | Acquisition | Sep 2020 | €60M |
| Jul 2020 |
| €107M |
| Atai Life Sciences | Series C | Nov 2020 | €105M |
| Sophia Genetics | Series D+ | Oct 2020 | €94M |
| Vectivbio | Other | Oct 2020 | €94M |
| Neogene Therapeutics | Other | Sep 2020 | €93M |
| Compass Pathways | Series B | Apr 2020 | €74M |
| Freeline Therapeutics | Series C | Jul 2020 | €71M |
| Lava Therapeutics | Series C | Sep 2020 | €70M |
| Melio | Series C | Sep 2020 | €68M |
| Compugen | Other | Mar 2020 | €68M |
| Pharvaris | Series C | Nov 2020 | €67M |
| Cera | Other | Feb 2020 | €65M |
